Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages

被引:438
作者
Liang, YC
Huang, YT
Tsai, SH
Lin-Shiau, SY
Chen, CF
Lin, JK
机构
[1] Natl Taiwan Univ, Coll Med, Inst Biochem, Taipei, Taiwan
[2] Acad Sinica, Inst Biol Chem, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan
[4] Natl Res Inst Chinese Med, Taipei, Taiwan
关键词
D O I
10.1093/carcin/20.10.1945
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins biosynthesis and nitric oxide production have been implicated in the process of carcinogenesis and inflammation, In this study, we investigated the effect of various flavonoids and (-)-epigallocatechin-3-gallate on the activities of inducible cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS) in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. Apigenin, genistein and kaempferol were markedly active inhibitors of transcriptional activation of COX-2, with IC50 < 15 mu M In addition, apigenin and kaempferol were also markedly active inhibitors of transcriptional activation of iNOS, with IC50 < 15 mu M. Of those compounds tested, apigenin was the most potent inhibitor of transcriptional activation of both COX-2 and iNOS, Western and northern blot analyses demonstrated that apigenin significantly blocked protein and mRNA expression of COX-2 and iNOS in LPS-activated macrophages, Transient transfection experiments showed that LPS caused an similar to 4-fold increase in both COX-2 and iNOS promoter activities, these increments were suppressed by apigenin, Moreover, electrophoretic mobility shift assay (EMSA) experiments indicated that apigenin blocked the LPS-induced activation of nuclear factor-kB (NF-kB), The inhibition of NF-kB activation occurs through the prevention of inhibitor kB (IkB) degradation, Transient transfection experiments also showed that apigenin inhibited NF-kB-dependent transcriptional activity. Finally, we showed that apigenin could inhibit the IkB kinase activity induced by LPS or interferon-gamma, The results of further studies suggest that suppression of transcriptional activation of COX-2 and iNOS by apigenin might mainly be mediated through inhibition of IkB kinase activity. This study suggests that modulation of COX-2 and iNOS by apigenin and related flavonoids may be important in the prevention of carcinogenesis and inflammation.
引用
收藏
页码:1945 / 1952
页数:8
相关论文
共 62 条
[2]   Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ [J].
Ajizian, SJ ;
English, BK ;
Meals, EA .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :939-944
[3]   THE INDUCIBLE TRANSCRIPTION ACTIVATOR NF-KAPPA-B - REGULATION BY DISTINCT PROTEIN SUBUNITS [J].
BAEUERLE, PA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (01) :63-80
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   ASSEMBLY AND REGULATION OF NADPH OXIDASE AND NITRIC-OXIDE SYNTHASE [J].
BASTIAN, NR ;
HIBBS, JB .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (01) :131-139
[6]   Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships [J].
Cao, GH ;
Sofic, E ;
Prior, RL .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (05) :749-760
[7]   APIGENIN AND TANGERETIN ENHANCE GAP JUNCTIONAL INTERCELLULAR COMMUNICATION IN RAT-LIVER EPITHELIAL-CELLS [J].
CHAUMONTET, C ;
BEX, V ;
GAILLARDSANCHEZ, I ;
SEILLANHEBERDEN, C ;
SUSCHETET, M ;
MARTEL, P .
CARCINOGENESIS, 1994, 15 (10) :2325-2330
[8]  
Chen CC, 1999, MOL PHARMACOL, V55, P481
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]   CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 EXPRESSION IN RHEUMATOID SYNOVIAL TISSUES - EFFECTS OF INTERLEUKIN-1-BETA, PHORBOL ESTER, AND CORTICOSTEROIDS [J].
CROFFORD, LJ ;
WILDER, RL ;
RISTIMAKI, AP ;
SANO, H ;
REMMERS, EF ;
EPPS, HR ;
HLA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1095-1101